// App-Quantinova.ai

5674 : Discovery of AZD9833, an oral small molecule selective degrader of the estrogen receptor (SERD)

Researchers

Presenter

  • James S. Scott

Principal Investigators

  • Thomas Moss

  • Steve Stokes

  • Willem M. Nissink

  • Christopher J. Morrow

  • Mandy Lawson

  • Natalie Cureton

  • Eric Gangl

  • Pablo Morentin Gutierrez

  • Richard Mather

  • Justin P. Lindemann

  • Andrew Sykes

  • David Fisher

  • Radoslaw Polanski

  • Danielle Carroll

  • Aisling Barton Twomey

  • Teresa Klinowska

Medical Centers

  • AstraZeneca, United Kingdom.

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Endometrial Cancer

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Estrogen Receptor 1

Drug/Treatment

  • Fulvestrant

  • Palbociclib

  • Tamoxifen

  • AZD-9496

Outcome

  • N/A

Study Design

  • Pharmacodynamics

Phase

  • NA

Study Id's

  • NCT03616587

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved